Only people whose health is at risk because of obesity get access, although some people who have prediabetes, are overweight or have a history of heart problems may also qualify, according to the Centers for Medicare & Medicaid Services
FAQ's They are primarily approved for type 2 diabetes (and semaglutide has approvals for obesity at specific doses)
The investment reflects the growing recognition of GLP-1 agonists as game-changing drugs in managing metabolic conditions, Dr
As Valentina Parma, a psychologist who studies human olfaction at the Monell Chemical Senses Center, put it: When food loses its pleasurable pull, other sensory sources for instance, music, texture, scent may fill that hedonic gap. To get a bit more scientific, Parma explained that GLP-1 receptors are found in the mitral cells of the olfactory bulb the brain region involved in processing smell as well as in the hippocampus